A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19

About this Study

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients

Sponsor Protocol ID:NCT04505774
IRB Number:2020V0136
Actively Enrolling
Observational/Not Applicable
October 22, 2020
Eligibility Criteria
18 years old
Both Male and Female

Inclusion Criteria
 1.  ≥ 18 years of age
 2. Hospitalized for COVID-19*
 3.  Enrolled within 72 hours of hospital admittance or 72 hours of                  positive COVID test
 4.  Expected to require hospitalization for > 72 hours

Exclusion Criteria
1.  Imminent death
2.  Requirement for chronic mechanical ventilation via tracheostomy              prior to hospitalization
3.  Pregnancy
4.  See arm-specific appendices.

Categories Click category to view its trials.
COVID-19 (Coronavirus)
Participating Locations
University Hospital
Contact Information
Contact Name: Dr. Matthew Kutcher
Phone Number: 601-815-1312
Email: mkutcher@umc.edu
Principal Investigator:Kutcher, Matthew E, M.D.
How to participate in our Clinical Trials